Oramed Pharmaceuticals Stock Market Value
ORMP Stock | USD 2.92 0.10 3.55% |
Symbol | Oramed |
Oramed Pharmaceuticals Price To Book Ratio
Is Oramed Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oramed Pharmaceuticals. If investors know Oramed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oramed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.14 | Revenue Per Share 0.033 | Quarterly Revenue Growth (1.00) | Return On Assets (0.05) | Return On Equity 0.0324 |
The market value of Oramed Pharmaceuticals is measured differently than its book value, which is the value of Oramed that is recorded on the company's balance sheet. Investors also form their own opinion of Oramed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oramed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oramed Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oramed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oramed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oramed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oramed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oramed Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oramed Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oramed Pharmaceuticals.
08/31/2023 |
| 03/28/2024 |
If you would invest 0.00 in Oramed Pharmaceuticals on August 31, 2023 and sell it all today you would earn a total of 0.00 from holding Oramed Pharmaceuticals or generate 0.0% return on investment in Oramed Pharmaceuticals over 210 days. Oramed Pharmaceuticals is related to or competes with Madrigal Pharmaceuticals, 23Andme Holding, Moleculin Biotech, Equillium, Mustang Bio, Seres Therapeutics, and Agilent Technologies. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of dia... More
Oramed Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oramed Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oramed Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 4.69 | |||
Information Ratio | 0.0637 | |||
Maximum Drawdown | 27.47 | |||
Value At Risk | (5.41) | |||
Potential Upside | 8.96 |
Oramed Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oramed Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oramed Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Oramed Pharmaceuticals historical prices to predict the future Oramed Pharmaceuticals' volatility.Risk Adjusted Performance | 0.0597 | |||
Jensen Alpha | 0.6389 | |||
Total Risk Alpha | (0.65) | |||
Sortino Ratio | 0.0656 | |||
Treynor Ratio | (0.26) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oramed Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Oramed Pharmaceuticals Backtested Returns
Oramed Pharmaceuticals appears to be very risky, given 3 months investment horizon. Oramed Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.1, which implies the firm had a 0.1% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Oramed Pharmaceuticals, which you can use to evaluate the volatility of the company. Please evaluate Oramed Pharmaceuticals' Risk Adjusted Performance of 0.0597, coefficient of variation of 1092.36, and Semi Deviation of 4.05 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Oramed Pharmaceuticals holds a performance score of 7. The company holds a Beta of -1.66, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Oramed Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Oramed Pharmaceuticals is expected to outperform it. Please check Oramed Pharmaceuticals' maximum drawdown, and the relationship between the information ratio and expected short fall , to make a quick decision on whether Oramed Pharmaceuticals' historical price patterns will revert.
Auto-correlation | -0.77 |
Almost perfect reverse predictability
Oramed Pharmaceuticals has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Oramed Pharmaceuticals time series from 31st of August 2023 to 14th of December 2023 and 14th of December 2023 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oramed Pharmaceuticals price movement. The serial correlation of -0.77 indicates that around 77.0% of current Oramed Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.77 | |
Spearman Rank Test | -0.37 | |
Residual Average | 0.0 | |
Price Variance | 0.16 |
Oramed Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Oramed Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oramed Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Oramed Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Oramed Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Oramed Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oramed Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oramed Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oramed Pharmaceuticals stock over time.
Current vs Lagged Prices |
Timeline |
Oramed Pharmaceuticals Lagged Returns
When evaluating Oramed Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oramed Pharmaceuticals stock have on its future price. Oramed Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oramed Pharmaceuticals autocorrelation shows the relationship between Oramed Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Oramed Pharmaceuticals.
Regressed Prices |
Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oramed Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oramed Pharmaceuticals' short interest history, or implied volatility extrapolated from Oramed Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Oramed Pharmaceuticals Correlation, Oramed Pharmaceuticals Volatility and Oramed Pharmaceuticals Alpha and Beta module to complement your research on Oramed Pharmaceuticals. To learn how to invest in Oramed Stock, please use our How to Invest in Oramed Pharmaceuticals guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Oramed Stock analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Oramed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.